These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 7897523

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO, Bolek TW, McCollough WM, Maria BL, Kedar A, Braylan RC, Mickle JP, Buatti JM, Mendenhall NP, Marcus RB.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):147-54. PubMed ID: 9747832
    [Abstract] [Full Text] [Related]

  • 24. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K, Taguchi H, Sawamura Y, Ikeda J, Aoyama H, Fujieda K, Ishii N, Kashiwamura M, Iwasaki Y, Shirato H.
    Jpn J Clin Oncol; 2008 Jul 01; 38(7):486-92. PubMed ID: 18573848
    [Abstract] [Full Text] [Related]

  • 25. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R.
    J Clin Oncol; 2006 Sep 01; 24(25):4202-8. PubMed ID: 16943538
    [Abstract] [Full Text] [Related]

  • 26. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T.
    J Neurosurg; 2009 Sep 01; 111(3):478-87. PubMed ID: 19231932
    [Abstract] [Full Text] [Related]

  • 27. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ.
    Lancet Oncol; 2006 Oct 01; 7(10):813-20. PubMed ID: 17012043
    [Abstract] [Full Text] [Related]

  • 28. Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
    Timmermann B, Kortmann RD, Kühl J, Meisner C, Dieckmann K, Pietsch T, Bamberg M.
    J Clin Oncol; 2002 Feb 01; 20(3):842-9. PubMed ID: 11821469
    [Abstract] [Full Text] [Related]

  • 29. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC, Donahue B, DaRosso R, Nirenberg A.
    Int J Radiat Oncol Biol Phys; 1996 Dec 01; 36(5):1155-61. PubMed ID: 8985038
    [Abstract] [Full Text] [Related]

  • 30. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
    Sirachainan N, Nuchprayoon I, Thanarattanakorn P, Pakakasama S, Lusawat A, Visudibhan A, Dhanachai M, Larbcharoensub N, Amornfa J, Shotelersuk K, Katanyuwong K, Tangkaratt S, Hongeng S.
    J Clin Neurosci; 2011 Apr 01; 18(4):515-9. PubMed ID: 21310618
    [Abstract] [Full Text] [Related]

  • 31. Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy.
    Pompe RS, von Bueren AO, Mynarek M, von Hoff K, Friedrich C, Kwiecien R, Treulieb W, Lindow C, Deinlein F, Fleischhack G, Kuehl J, Rutkowski S.
    Eur J Cancer; 2015 Nov 01; 51(17):2634-42. PubMed ID: 26346136
    [Abstract] [Full Text] [Related]

  • 32. Local control in non-metastatic medulloblastoma.
    Christopherson KM, Bradley JA, Rotondo RL, Pincus DW, Fort JA, Morris CG, Mendenhall NP, Marcus RB, Indelicato DJ.
    Acta Oncol; 2014 Sep 01; 53(9):1151-7. PubMed ID: 24991891
    [Abstract] [Full Text] [Related]

  • 33. [High-dose chemotherapy in relapse of medulloblastoma in young children].
    Dupuis-Girod S, Hartmann O, Benhamou E, Doz F, Mechinaud F, Bouffet E, Coze C, Kalifa C.
    Bull Cancer; 1997 Mar 01; 84(3):264-72. PubMed ID: 9207872
    [Abstract] [Full Text] [Related]

  • 34. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS.
    Eur J Cancer; 2005 Mar 01; 41(5):727-34. PubMed ID: 15763649
    [Abstract] [Full Text] [Related]

  • 35. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
    Hughes EN, Shillito J, Sallan SE, Loeffler JS, Cassady JR, Tarbell NJ.
    Cancer; 1988 May 15; 61(10):1992-8. PubMed ID: 3129177
    [Abstract] [Full Text] [Related]

  • 36. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 37. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
    Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G, Garrè ML, Ricardi U, Forni M, Genitori L, Scarzello G, Spreafico F, Barra S, Mascarin M, Pollo B, Gardiman M, Cama A, Navarria P, Brisigotti M, Collini P, Balter R, Fidani P, Stefanelli M, Burnelli R, Potepan P, Podda M, Sotti G, Madon E, AIEOP Pediatric Neuro-Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1336-45. PubMed ID: 15050308
    [Abstract] [Full Text] [Related]

  • 38. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    Kellie SJ, Chaku J, Lockwood LR, O'Regan P, Waters KD, Wong CK, Australian and New Zealand Children's Haematology Oncology Group.
    Eur J Cancer; 2005 Jul 01; 41(11):1588-96. PubMed ID: 16026694
    [Abstract] [Full Text] [Related]

  • 39. Ependymal tumors in childhood.
    Agaoglu FY, Ayan I, Dizdar Y, Kebudi R, Gorgun O, Darendeliler E.
    Pediatr Blood Cancer; 2005 Sep 01; 45(3):298-303. PubMed ID: 15770637
    [Abstract] [Full Text] [Related]

  • 40. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P, Kun LE, Hustu HO, Mulhern RK, Hancock ML, Coffey D, Rivera GK.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):477-83. PubMed ID: 7852109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.